Works matching IS 19466234 AND DT 2018 AND VI 10 AND IP 427

Results: 5

PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL<sup>+</sup> human leukemia.
Published in:
Science Translational Medicine, 2018, v. 10, n. 427, p. 1, doi. 10.1126/scitranslmed.aan8735
By:
- Lai, Damian;
- Chen, Min;
- Su, Jiechuang;
- Liu, Xiaohu;
- Rothe, Katharina;
- Hu, Kaiji;
- Forrest, Donna L.;
- Eaves, Connie J.;
- Morin, Gregg B.;
- Jiang, Xiaoyan
Publication type:
Article
Targeting mitochondrial responses to intra-articular fracture to prevent posttraumatic osteoarthritis.
Published in:
Science Translational Medicine, 2018, v. 10, n. 427, p. 1, doi. 10.1126/scitranslmed.aan5372
By:
- Coleman, Mitchell C.;
- Goetz, Jessica E.;
- Brouillette, Marc J.;
- Seol, Dongrim;
- Willey, Michael C.;
- Petersen, Emily B.;
- Anderson, Hope D.;
- Hendrickson, Nathan R.;
- Compton, Jocelyn;
- Khorsand, Behnoush;
- Morris, Angie S.;
- Salem, Aliasger K.;
- Fredericks, Douglas C.;
- McKinley, Todd O.;
- Martin, James A.
Publication type:
Article
Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.
Published in:
Science Translational Medicine, 2018, v. 10, n. 427, p. 1, doi. 10.1126/scitranslmed.aao0144
By:
- Jeong, Mark Y.;
- Lin, Ying H.;
- Wennersten, Sara A.;
- Demos-Davies, Kimberly M.;
- Cavasin, Maria A.;
- Mahaffey, Jennifer H.;
- Monzani, Valmen;
- Saripalli, Chandrasekhar;
- Mascagni, Paolo;
- Reece, T. Brett;
- Ambardekar, Amrut V.;
- Granzier, Henk L.;
- Dinarello, Charles A.;
- McKinsey, Timothy A.
Publication type:
Article
Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance.
Published in:
Science Translational Medicine, 2018, v. 10, n. 427, p. 1, doi. 10.1126/scitranslmed.aam8604
By:
- Yin, Lei-Miao;
- Xu, Yu-Dong;
- Peng, Ling-Ling;
- Duan, Ting-Ting;
- Liu, Jia-Yuan;
- Xu, Zhijian;
- Wang, Wen-Qian;
- Guan, Nan;
- Han, Xiao-Jie;
- Li, Hai-Yan;
- Pang, Yu;
- Wang, Yu;
- Chen, Zhaoqiang;
- Zhu, Weiliang;
- Deng, Linhong;
- Wu, Ying-Li;
- Ge, Guang-Bo;
- Huang, Shuang;
- Ulloa, Luis;
- Yang, Yong-Qing
Publication type:
Article
Targeting p53-dependent stem cell loss for intestinal chemoprotection.
Published in:
Science Translational Medicine, 2018, v. 10, n. 427, p. 1, doi. 10.1126/scitranslmed.aam7610
By:
- Leibowitz, Brian J.;
- Yang, Liheng;
- Wei, Liang;
- Buchanan, Monica E.;
- Rachid, Madani;
- Parise, Robert A.;
- Beumer, Jan H.;
- Eiseman, Julie L.;
- Schoen, Robert E.;
- Zhang, Lin;
- Yu, Jian
Publication type:
Article

Works matching IS 19466234 AND DT 2018 AND VI 10 AND IP 427

PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL<sup>+</sup> human leukemia.

Targeting mitochondrial responses to intra-articular fracture to prevent posttraumatic osteoarthritis.

Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.

Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance.

Targeting p53-dependent stem cell loss for intestinal chemoprotection.